Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment.
Times cited: 24
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma.
Times cited: 51
Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
Journal of Clinical Oncology.
Times cited: 172